Package 67751-239-02

{"route": ["ORAL"], "spl_id": "435b5b96-73d0-4d01-e063-6394a90ae4dd", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["435b4a2a-d6bf-ec25-e063-6294a90a3f06"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-239-01)  / 2 TABLET, COATED in 1 POUCH", "package_ndc": "67751-239-01", "marketing_start_date": "20250219"}, {"sample": false, "description": "2 POUCH in 1 CARTON (67751-239-02)  / 2 TABLET, COATED in 1 POUCH", "package_ndc": "67751-239-02", "marketing_start_date": "20250219"}], "brand_name": "Tylenol Sinus Severe", "product_id": "67751-239_435b5b96-73d0-4d01-e063-6394a90ae4dd", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "67751-239", "generic_name": "Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Tylenol Sinus Severe", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250219", "listing_expiration_date": "20261231"}